Paragon Ventures Archives

July 14, 2022

Elucidating the pathogenesis of COVID-19-related coagulopathies and evaluation of medical countermeasures

Various blood clotting disorders have been associated with COVID-19. The underlying cause of the problem remains unknown. This research project aims to tease out the underlying biological causes and evaluate potential treatments.

July 14, 2022

Evaluation of terminal complement cascade inhibitors using in vitro and in vivo models of age-related macular degeneration and in Alzheimer’s Disease

Age-related macular degeneration (AMD) is a leading cause of blindness that is estimated to affect over 6 million people globally. There are currently no approved treatments for dry AMD, the most common form of the disease. Various lines of inquiry suggest that dysregulation of a part of the innate immune system called complement plays a […]

About Mitacs

Where we invest

Partner with us

Paragon Ventures

Join a thriving innovation ecosystem.

Subscribe to our newsletter now!